Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cell biology evolves into clinical application

Derek N J Hart1

  • 1Dendritic Cell Laboratory, Mater Medical Research Institute, Raymond Terrace, South Brisbane, Queensland 4101, Australia. dhart@mmri.mater.org.au

Lancet (London, England)
|January 11, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinguishing human peripheral blood CD16<sup>+</sup> myeloid cells based on phenotypic characteristics.

Journal of leukocyte biology·2019
Same author

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

Molecular oncology·2019
Same author

CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.

Frontiers in immunology·2019
Same author

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.

PloS one·2019
Same author

The cell surface phenotype of human dendritic cells.

Seminars in cell & developmental biology·2018
Same author

Dendritic cells as cancer therapeutics.

Seminars in cell & developmental biology·2018
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles